ERBB2 and bone metastasis: Luminal-like subtype LMBC exhibited a higher rate of bone metastasis (P < 0.0001), while the HER2 overexpression subtype, including HR+/HER2+ and HR−/HER2+, tended to be associated with a relatively higher occurrence of liver metastasis (P < 0.0001).